Predictors of Ocrelizumab Effectiveness in Patients with Multiple Sclerosis
2021 · Neurotherapeutics · 38 citations
https://doi.org/10.1007/s13311-021-01104-8
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
42
Papers
638
Citations
15
h-index
16
i10-index
Elvira Sbragia is an academic researcher from Ente Ospedaliero Ospedali Galliera. The author has contributed to research in topics: Multiple Sclerosis Research Studies & Peripheral Neuropathies and Disorders & SARS-CoV-2 and COVID-19 Research. The author has an h-index of 15, co-authored 36 publications.
ORCID: 0000-0002-5903-8535https://doi.org/10.1007/s13311-021-01104-8
https://doi.org/10.1186/s41747-022-00277-x
Click to start Chat